CLPT News and Press, ClearPoint Neuro, Inc. From 11/05/25

SOLANA BEACH, CALIFORNIA / ACCESS Newswire / November 5, 2025 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced it will participate in the following investor confe...

2025-10-08 15:33:48 ET uniQure’s ( QURE ) stock skyrocketed in late September after the announcement of stronger-than-expected Huntington’s trial data. Despite a more than 300% increase in the share price, the market still seems to be undervaluing uniQure, which likely ste...

SOLANA BEACH, CALIFORNIA / ACCESS Newswire / October 7, 2025 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced results from a Phase I-II clinical study at Skå...

The clearly established history across global regulatory bodies is expected to de-risk BioPharma partners' pathways towards achieving global scale and standardization. SOLANA BEACH, CALIFORNIA / ACCESS Newswire / October 6, 2025 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a gl...

2025-10-03 09:48:17 ET Shares of ClearPoint Neuro, Inc. (NASDAQ: CLPT) traded at a new 52-week high today and are currently trading at $28.02. So far today, approximately 800.6k shares have been exchanged, as compared to an average 30-day volume of 1.25M shares. ClearPoint Neuro, In...

2025-10-03 09:46:13 ET DENVER, Colo., Oct 03, 2025 ( 247marketnews.com )- Markets are trading with conviction this morning as tech, media, and entertainment names push forward on news catalysts. Here’s what’s driving the tape: Rumble (NASDAQ:RUM) announced a stra...

2025-10-02 17:05:56 ET ClearPoint Neuro's ( CLPT ) share price recently surged on the back of uniQure's ( QURE ) extremely strong Huntington's data. While the financial impact of AMT-130 should be meaningful, the data is more important as confirmatory evidence of the strength of Cle...

New Product Category Will Enable Added Flexibility to Support Commercial Launches of Cell and Gene Therapy SOLANA BEACH, CALIFORNIA / ACCESS Newswire / October 1, 2025 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering...

2025-09-29 09:51:45 ET Shares of ClearPoint Neuro, Inc. (NASDAQ: CLPT) traded at a new 52-week high today and are currently trading at $20.68. So far today, approximately 243.47k shares have been exchanged, as compared to an average 30-day volume of 1.2M shares. ClearPoint Neuro, In...

2025-09-25 17:50:00 ET Introduction ClearPoint Neuro, Inc. ( CLPT ), caught my eye today. Its stock has rallied over 100% in just the last few days, and yet, there is no official news/press release from the company. Upon some research, I soon discovered that ClearPoint is tradin...